The CDY (Chromodomain on the Y) family is a small family of chromodomain containing proteins, whose chromodomains closely resemble those in HP1 and Polycomb. The CDY proteins play an essential role in normal spermatogenesis and brain development. Dysregulation of their expression has been linked to male infertility and various neurological diseases. Like the chromodomains of HP1 and Polycomb, the CDY chromodomains also recognize the lysinemethylated ARKS motif embedded in histone and non-histone proteins. Interestingly, the CDY chromodomains exhibit different binding preferences for the lysine-methylated ARKS motif in different sequence contexts. Here, we present the structural basis for selective binding of CDY1 to H3K9me3 and preferential binding of CDYL2 to H3tK27me3 over H3K27me3. Based on our structural, binding and mutagenesis data, we synthesized a more CDYL1/2 selective peptidic ligand UNC4850. Our work provides critical implications that CDYL1b's role in the regulation of neural development is dependent on its recognition of lysine-methylated ARKS motifs. morphology by repressing BDNF, a key regulator in dendrite development 16 ; it modulates neuronal intrinsic plasticity by repressing SCN8A, a sodium channel gene whose mutations cause epileptic encephalopathies 17 ; it controls neuronal migration by repressing RhoA, a gene involved in actin cytoskeleton regulation, and its deficiency causes neuronal migration disorders and increased susceptibility to epilepsy 18 ; and it contributes to stress-induced depression by repressing VGF (or VGF nerve growth factor inducible), a gene that plays a key role in synaptic plasticity 19 . CDYL1 represses expression of its target genes through recruitment of PRC2mediated H3K27me3 activity 16,17,19 , and possibly also through its own histone crotonylation ability 19 . In addition to recruiting PRC2 and its associated H3K27me3 activity, CDYL1 also recruits G9a, a histone H3K9 dimethyltransferase, which together with REST represses transcription of potential tumor suppressor genes 15 . Not surprisingly, both CDYL and G9a are upregulated in hepatocellular carcinoma (HCC), but not in non-cancerous liver tissues 20 . CDYL1 also associates with chromatin assembly factor 1 (CAF1) and the MCM complex, and recruits histone H3K9/27 methyltransferases G9a, SETDB1, and PRC2 to the replication forks for transmission of repressive chromatin marks during DNA replication 21 , or to DNA double-strand break (DSB) sites for transcriptional silencing and promotion of homology-directed DNA repair (HDR) 22 .
Introduction
The CDY (Chromodomain on the Y) gene family originates from the autosomal gene CDYL1 (CDY-like 1) 1,2 . Over the evolutionary timeline, the CDYL1 gene was duplicated to create another autosomal gene CDYL2, and retroposed into the Y chromosome to generate CDY, which was further amplified into CDY1 and CDY2. CDY1 and CDY2 are highly similar at both the DNA and protein sequence levels (>98% identity), and both genes contain two almost identical copies. The CDY family proteins contain two conserved domains: a canonical chromodomain in the N-terminus and a crotonase-like catalytic domain in the C-terminus ( Fig. S1a and Fig. S2 ) 3 .
The chromodomains of the CDY family are highly homologous to chromodomains in HP1 and Polycomb, and as such, they also recognize the lysine-methylated ARKS motif embedded in histone and non-histone proteins 4, 5 . The catalytic domain of mouse CDYL1 has been reported to exhibit crotonyl-CoA hydratase activity 6 .
The CDY family of genes display diverse expression patterns. All human CDY family genes are abundantly expressed in testis (Fig. S1b) , and their normal expression is required for complete spermatogenesis 7, 8 . Deletion of either CDY1 or CDY2 leads to spermatogenic failure and male infertility 9-12 , and it has been proposed that CDY2 and CDY1 function in the early and later stages of spermatogenesis, respectively 7 . However, over the process of evolution, non-simian mammals have been shown to lack the Y-linked CDY genes 2 . Nevertheless, in mice, a short transcript of CDYL1 displays testis-specific expression 1,2 , and the normal expression of mouse CDYL1 is essential for spermatogenesis and male fertility, similar to human CDY1/2 genes 6, 13 . Both human and mouse CDYL1 function as transcriptional corepressors 14, 15 . This CDYL1-mediated repressive function has recently been linked to its role in converting crotonyl-CoA, an active mark in transcription, to β -hydroxybutyryl-CoA 6 , and this crotonyl-CoA hydratase activity contributes to its role in spermatogenesis 6 . However, in another mouse study, conditional knockout of CDYL1 does not affect global histone crotonylation, but causes disordered patterns of histone methylation and acetylation in testis 13 .
Mouse CDYL1 is also involved in brain development, and its dysregulation has been linked to different neurological disorders [16] [17] [18] [19] . For instance, CDYL1 regulates dendritic growth and Our ITC binding results reveal that CDY1 is highly specific toward H3K9me3, with more than 60-fold selectivity over the H3tK27me3 and H3K27me3 peptides (K d ~0.5 μM vs. 32 μM and 93 μM, Fig. 1b ). On the other hand, CDYL1b and CDYL2 bind to these three peptides with a slight preference for H3K9me3 and H3tK27me3. Hence, the Y-chromosomal CDY1 is a specific reader of H3K9me3, whereas autosomal CDYL1b and CDYL2 are preferential binders of both H3K9me3 and testis-specific H3tK27me3 in vitro.
Structural basis for selective binding of CDY1 to H3K9me3
To reveal why Y-linked CDY1 is a specific reader of H3K9me3, we determined the crystal structure of the CDY1 chromodomain in complex with an H3K9me3 peptide ( Supplementary   Table 1 ). Not surprisingly, the CDY1 chromodomain exhibits a canonical chromodomain fold, consisting of three β-strands followed by a C-terminal α helix, and binds to H3K9me3 in a similar manner to that observed in the complex structures of the HP1 and Pc subfamily of chromodomains with histone H3K9/K27 peptides [28] [29] [30] [31] [32] [33] . The histone H3K9me3 peptide, together with the chromodomain's N-terminus (β0), forms a short anti-parallel, double-stranded β -sheet on one side, and on the other side interacts with the chromodomain region just C-terminal of η 2 ( Fig. 2a ). The ARKS motif is recognized through a conserved binding mode [28] [29] [30] [31] [32] [33] . In brief, the K9me3 residue is recognized by a conserved aromatic cage formed by F6′, W28′ and Y31′ ( Fig.   1c and 2b) (hereinafter, chromodomain residue numbers are marked with a prime (′) to distinguish them from the histone residue numbers). The histone H3A7 residue at the n-2 position (n represents the methyllysine residue) is buried in a hydrophobic pocket formed by V8′, V26′, W28′ and L44′ (Fig. 2b) . The hydroxyl group of H3T6 forms a hydrogen bond with the carboxyl group of E5′ in CDY1. An equivalent hydrogen bond would be absent in binding H3K27me3 or H3tK27me3 which contain an alanine and valine at this position, respectively ( Fig.   1a ), which helps to explain the observed selectivity for the H3K9me3 sequence. CDY1 E5′ can additionally interact with the CDY1 N46′ side chain, located at the opposite edge of the peptidebinding groove (Fig. 2b) . This arrangement to some extent resembles a pair of glutamic acid and aspartic acid residues in CBX1/3/5, which also exhibit strong selectivity toward H3K9me3 (Fig.   1c ) 31 . Here, CDY1 also uses a similar E-N clasp for the selective H3K9me3 binding.
Structural basis for preferential binding of H3tK27me3 over H3K27me3 by CDYL2
Previous studies have extensively investigated the structural basis for the binding of the HP1 and Pc subfamily of chromodomains to the lysine-methylated ARKS motif in H3K9me3/H3K27me3 [28] [29] [30] [31] [32] [33] [34] . However, it is still not clear how CDYL1b and CDYL2 achieve preferential binding to the testis-specific H3tK27me3. Because H3tK27me3 also harbors an ARKS motif, sequences immediately outside the ARKS motif might contribute to the binding preference. The H3tK27me3 peptide shows a single substitution, A24V, compared to the canonical H3K27me3 peptide (Fig. 1a) . To see if the H3t-specific V24 immediately preceding the ARKS motif contributes to the binding preference, we determined the crystal structures of the CDYL2 chromodomain bound to the H3tK27me3 peptide or the H3K27me3 peptide, respectively ( Supplementary Table 1 , Fig. 2d-2f and Fig. S3a ). The CDYL2 chromodomain in the CDYL2-H3tK27me3 complex displays a canonical chromodomain fold. However, in the CDYL2-H3K27me3 complex, the C-terminal α-helix of CDYL2 in one monomer is swayed away from its chromodomain core and occupies a similar position on another, crystal symmetryrelated chromodomain molecule, thus forming a loose chromodomain homodimer (Fig. S3a ).
This unusual reorientation of the C-terminal α-helix and consequent dimerization may be caused by crystal packing, as our NMR solution structure of this chromodomain indicates a canonical chromodomain fold ( Fig. S3b ).
In the CDYL2-H3tK27me3 structure, V24 of the H3tK27me3 peptide packs against a "hydrophobic clasp" formed by L6′ and L46′ (referred to as L-L clasp as in reference 31 ). V24 and R26 of the H3t peptide clasp the "L-L clasp" in turn (Fig. 2d ). The methyl group of H3tA21 also packs against the H3tV24 side chain such that the H3t-specific residue V24 is largely buried in a hydrophobic groove ( Fig. 2d and e ). The equivalent methyl side chain of A24 in the canonical H3K27me3 peptide engages in less extensive hydrophobic interactions than the isopropyl side chain of H3tV24 (Fig. 2f ). In the context of H3K9me3, the residue corresponding to V24 of H3tK27me3 is T6 ( Fig. 2c ). Valine and threonine differ by mere substitution of a hydroxyl for a methyl group in the amino acid's γ position; a lack of strong selectivity between H3K9me3 and H3tK27me3 is thus not surprising.
CDYL1b regulates neural development dependent on its recognition of lysine-methylated

ARKS motifs
Our previous studies have shown that CDYL1b plays a vital role in neural development, and the gene repression of BDNF and RhoA mediated by CDYL1b is required for dendritic branching and neuronal migration 16, 18 . Since the chromatin association of CDYL1b depends on its recognition of H3K9me2, H3K9me3 and H3K27me3 marks 5, 16, 21, 23, 24 , presumably a fully functional chromodomain is critical for CDYL1b to function properly in neural development.
The use of a cell immunofluorescence staining assay revealed that flag-tagged CDYL1b colocalized with the H3K9me3 mark in the neuro-2a cell line ( Fig. 3a and b ). Our structural data
show that the methyllysine-binding aromatic cage is composed of Y7′, W29′ and Y32′ in CDYL2 and is highly conserved in the CDYL1b ( Fig. 1c and 2d ). It is well known that the aromatic cage is essential in recognizing the lysine methylation marks 35 . Accordingly, when we mutated the cage residues of the CDYL1b chromodomain, such as Y7A′, W29A′ and Y32A′,
CDYL1b is mislocalized and becomes diffuse in the nucleus (Fig. 3a-c) , presumably due to the loss of its interaction with H3K9me3 ( Fig. 3d ). In contrast, mutations of residues that are not critical for binding including K30A′ or G31A′ did not affect the colocalization of CDYL1b and H3K9me3 ( Fig. 3d ). Hence, CDYL1b is localized to chromatin in the neuro-2a cells via the recognition of the lysine-methylated ARKS motif-containing histone marks.
CDYL1b has also been shown to suppress dendritic morphogenesis through its association with chromatin 16 . Indeed, wild-type CDYL1b distinctly restricted dendritic branching, but its aromatic cage mutants Y7A′, W29A′ or Y32A′ were defective in the regulation of dendritic branching ( Fig. 4a and b ). As a control, the K30A′ mutant resembled wild-type CDYL1b. We next investigated whether CDYL1b regulates neuronal migration via binding to methylated histone marks. Knockdown of CDYL1b by a short hairpin RNA (shRNA) has been shown to result in defective neuronal migration 18 . We co-expressed CDYL1b-R-WT that is resistant to CDYL1b shRNA and showed that this is sufficient to restore neuronal migration. However, the Y7A′, W29A′ or Y32A′ mutants of CDYL1b-R failed to restore neuronal migration ( Fig. 4c and d ).
Taken together, these results highlight the important role of CDYL1b in regulating neural development through its interaction with histone marks (H3K9me3/H3K27me3) by its functional chromodomain.
Utilization of a CBX4/7-specific chemical probe UNC3866 to investigate the binding selectivity of chromodomains
UNC3866 is a peptidomimetic chemical probe which targets the Polycomb CBX family of chromodomains and binds to CBX4 and CBX7 most potently with a K d of ~ 100 nM for both proteins. It was designed based on the H3K27me3 peptide and a SETDB1 fragment (GFALKme3S) 25, 31, 36, 37 . Both previous 25, 38 and our current binding studies have shown that UNC3866 also binds to the chromodomains of the CDY subfamily and MPP8 with a preference for the CDYL1/2 chromodomains. In order to understand the binding specificity of UNC3866 by the ARKme3S binding chromodomains, we crystallized UNC3866 in complex with the chromodomains of CDYL2 and MPP8, in addition to the CBX2/4/7/8-UNC3866 structures we solved previously 25 . By analyzing all of the available structures of the ARKme3S binding chromodomains in complex with UNC3866, we found that the nature of the chromodomain clasp influences UNC3866 binding selectivity (Fig. 5 ). The hydrophobic clasps from the CDYL1/2 and CBX2/4/7/8 chromodomains make hydrophobic interactions with the Phe and Leu side chains of UNC3866 ( Fig. 5a ). In contrast, the CBX1/3/5 and SUV39H1/2 chromodomains have charged clasp pairs and could not form such hydrophobic interactions ( Fig. 1c ). Accordingly, the CBX1/3/5 and SUV39H1/2 chromodomains displayed negligible binding to UNC3866 (Fig. 5b ).
MPP8 has a mixed V-D clasp, which exhibits weaker hydrophobic interactions with UNC3866 based on its complex structure ( Fig. 5a ) and binds to UNC3866 with a significantly reduced affinity ( Fig. 5b ).
In addition, the N-terminal tert-butylphenyl group of UNC3866 is accommodated in a largely hydrophobic groove in the CBX4/7 structures ( Fig. 5d ). Specifically, V13′ and L53′ of CBX7 packs snugly against the tert-butylphenyl group of UNC3866. But, in CBX2/6/8, an alanine residue replaces the V13′ residue of CBX7 ( Fig. 1c ), which may explain why CBX2/6/8 exhibit weaker binding to UNC3866. Like in CBX4/7, there is a valine at the corresponding position of the CDYL2 chromodomain ( Fig. 1c ), which may explain why CDYL2 shows higher binding affinity to UNC3866 than CBX2/6/8. In order to confirm this, we made the CBX7_V13A′ and CBX2_A14V′ mutants, and our binding results revealed that these substitutions reversed the binding affinities of CBX7 and CBX2 towards UNC3866 ( Fig. 5b) , with a greater than 40-fold increase in potency with CBX2_A14V′ over wild-type CBX2. This is further confirmed by our crystal structure of the CBX7_V13A′ mutant in complex with UNC3866. In this mutant structure, the alanine residue did not pack as snugly as the valine residue against the tert-butylphenyl group of UNC3866 ( Fig. 5d ). Taken together, this series of structures of UNC3866 in complex with different chromodomains has the potential to assist in the design of more selective chemical probes for these chromodomains in the future.
Design and synthesize a CDYL1/2-specific compound UNC4850
Previously, we found that substituting the tert-butylphenyl capping group with an aliphatic isobutyl or cyclohexyl group resulted in increased selectivity for CDYL2 over CBX7, suggesting that chromodomain selectivity could be modulated at the N-terminal capping position 38 . And structural analysis reveals that, unlike in the CBX7 25 , H47′, E50′ and F51′ of CDYL2 form an incompact pocket packing against the tert-butylphenyl group of UNC3866, and hence, although the valine residue V9′ corresponding to V13′ of CBX7 is conserved, CDYL2 does not form strong interactions with the tert-butylphenyl group like CBX7 ( Fig. 6a ). Consequently, we synthesized and evaluated a similar ligand, UNC4850, which is a close analog of UNC3866 and contains an isobutyl N-terminal cap ( Fig. 6b ). As expected, UNC4850 binds to the chromodomain of CDYL1/2 about 10-fold more potently than to that of CBX7 by ITC ( Fig. 6c ).
We also determined its complex structure with CDYL2. However, this complex structure displayed a similar crystal packing as we observed in the CDYL2-H3K27me3 complex ( Fig.   S3c ), but unlike the UNC3866 complex structure. Notwithstanding this discrepancy, UNC3866
and UNC4850 occupy a conserved binding pocket (Fig. S3c ). The smaller isobutyl cap of UNC4850 fits into the rearranged hydrophobic groove formed by V9′ and F51′ of CDYL2. In addition to a difference in the N-terminus, the leucine residue of UNC3866 is replaced with a phenylalanine residue in UNC4850, which is able to form stronger hydrophobic interactions with the conserved hydrophobic residues L6′ and L46′ ( Fig. 6d ). Therefore, UNC4850 is a specific small-molecule inhibitor toward CDYL1/2.
Methods
Cloning, protein expression and purification
The following DNA fragments were cloned into a pET28a-MHL vector: CDY1 (aa 2-63), CDYL2 (aa 2-62 or 2-64), CBX2 (aa 9-62), CBX5 (aa 18-75), CBX7 (aa 8-62) and MPP8 (aa 56-116). CDYL1b (aa 1-66) was cloned into pET28GST-LIC. Protein expression was induced by 0.3 mM IPTG at 16 o C overnight, and proteins were purified by a Ni-NTA or GST column followed by ion exchange chromatography and size exclusion chromatography. His-tag or GSTtag was removed by the addition of TEV or Thrombin proteases. Uniformly 15 N-and 15 N/ 13 Clabeled proteins were prepared by growing bacteria in M9 media using 15 NH 4 Cl (0.5 g/liter) and 13 C 6 -glucose (2.5 g/liter) as stable isotope sources. Mutations were introduced with the QuikChange II XL Site-Directed Mutagenesis Kit (Stratagene) and confirmed by DNA sequencing. Mutants were overexpressed and purified as the wild-type constructs above.
Isothermal Titration Calorimetry
The ITC titrations between chromodomain proteins and UNC4850 were recorded at 25 °C with an Auto-iTC200 isothermal titration calorimeter (MicroCal Inc., USA). All protein and compound stock samples were prepared in an ITC Buffer (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 2 mM β -mercaptoethanol) and then diluted to achieve the desired concentrations.
Either 50 μM or 100 μM protein and 0.5 mM or 1.0 mM compound were used, respectively, to maintain a 10:1 compound to protein molar ratio for all ITC experiments. The concentration of the protein stock solution was established using the Edelhoch method, whereas compound stock 
Protein crystallization
The chromodomains of CDYL2, CDY1, CBX7_V13A and MPP8 mixed with 1.5-3.0 fold peptide or compounds were crystallized using sitting drop vapor diffusion method by mixing 1 μL protein with 1 μL reservoir solution. The crystal of CDYL2 in complex with H3tK27me3 was obtained at 4 °C and the others were grown at 18°C. The CDYL2-H3K27me3 complex was COOT was used for interactive model rebuilding. PHENIX and REFMAC were used for restrained model refinement 44, 47 . An anomalous scatterer near the protein constructs N-terminus was tentatively assigned as a nickel cation. The geometry of that ion's coordination was restrained based on the results of a MOGUL 48 search.
CDYL2-H3K27me3: Diffraction data were collected at beamline 19ID of the Advanced Photon
Source and reduced alternatively with DENZO/SCALEPACK or XDS. The structure was solved by molecular replacement with the program PHASER 49 and coordinates from PDB entry 4HAE.
ARP/wARP was used for map improvement 50 . COOT was used for interactive model building.
REFMAC and AUTOBUSTER 51 were used for restrained model refinement.
CDYL2-UNC3866: Diffraction data were collected on a copper rotating anode source.
Inspection of the set of diffraction images revealed the emergence of ice rings in the course of data collection. Data were initially processed with DENZO/SCALEPACK, and later with the XIA2 XDS/AIMLESS pipeline applying the "exclude_ice_regions" option. Molecular replacement was performed with PHASER and an ensemble comprising of preliminary versions of PDB entries 5EPJ and 5EPK 25 . After phase modification with ARP/wARP and PARROT 52 , the model was traced with the BUCCANEER pipeline 53 . Further model rebuilding and refinement were performed with COOT and REFMAC, respectively. Geometry restraints for UNC3866 were prepared using GRADE 54 , MOGUL and JLIGAND 55 .
CBX7-(V13A)-UNC3866: Diffraction data were collected on a copper rotating anode source and processed with the XIA2 XDS/AIMLESS pipeline. Preliminary coordinates of isomorphous PDB entry 5EPJ were used as a starting model for restrained refinement with REFMAC and interactive rebuilding with COOT.
MPP8-UNC3866: Diffraction data were collected on a copper rotating anode source and processed through the XIA2 XDS/AIMLESS pipeline. The structure was solved by molecular replacement with the program PHASER and coordinates from PDB entry 3R93 38 . COOT 43 and REFMAC 44 were used for model interactive rebuilding and restrained refinement, respectively.
CDYL2-UNC4850: Diffraction data were collected at APS beamline 22ID and reduced with DENZO/SCALEPACK or, for later stages of model refinement, the XIA2 XDS/AIMLESS pipeline. The structure was solved by molecular replacement with the program PHASER and a search model derived from the CDYL2-UNC3866 complex (see above). The model was rebuilt automatically with PHENIX AUTOBUILD. COOT, REFMAC and PHENIX were used for additional rebuilding and refinement of the model. Some geometry restraints for the UNC4850 ligand were prepared on the GRADE server (http://www.globalphasing.com).
NMR structure determination
Solution structure of the CDYL2 chromodomain was determined using the ABACUS approach 56 from NMR data collected at high resolution from nonlinearly sampled spectra and processed using multidimensional decomposition 57,58 . NMR spectra were recorded at 25 °C on Bruker
Avance 800-MHz spectrometers equipped with cryoprobes. The sequence-specific assignment of 13 C, 1 H, and 15 N resonances were assigned using the ABACUS protocol 56 from peak lists derived from manually peak picked spectra. The restraints for backbone φ and ψ torsion angles were derived from chemical shifts of backbone atoms using TALOS+ 59 . Hydrogen bond constraints were used within regular secondary structure elements. Automated NOE assignment 60 and structure calculations were performed using CYANA (Version 3.0) according to its standard protocol. The final 20 lowest-energy structures were refined within CNS1.3 61 by a short constrained molecular dynamics simulation in explicit solvent 62 . 
Plasmids for cellular assays and in utero electroporation
Immunofluorescence Staining
Cells were washed with 0.1 M PBS twice and then fixed in 4% paraformaldehyde (PFA) for 10 min. After three times 5 min washing with 0.1 M PBS, cells were permeabilized with 0.1%
Triton TM X-100 in 0.1 M PBS for 20 min at room temperature and then blocked with 3% bovine albumin (BSA) in 0.1 M PBS with 0.3% Triton TM X-100 for 1 hour at room temperature. Next, cells were incubated overnight at 4 °C with monoclonal anti-FLAG M2 antibody (1:1000, F1804, Sigma-Aldrich, Germany) and polyclonal rabbit anti-H3K9me3 antibody (1:100, A2360, ABclonal, China). Next day, after three times 5 min washing with 0.1 M PBS, cells were incubated for 1 hour at room temperature with donkey anti-mouse Alexa Fluor 594 antibody
(1:1000, A-21203, Thermo Fisher Scientific, USA) and donkey anti-rabbit Alexa Fluor 555 antibody (1:1000, A-31572, Thermo Fisher Scientific, USA). Finally, cells were counterstained with Hoechst 33342 (10 μ g/ml, C0031, Solarbio, China) and mounted with antifading mounting medium (S2100, Solarbio, China).
Colocalization analysis
Cells were captured at a 63x/1.40 NA Silicon Immersion objective lens with 4× digital zoom 
Primary neuron culture, transfection and reagents
Primary mouse hippocampal neurons were prepared as previously described 16 
In utero electroporation
In utero electroporation was performed on E14.5 mouse brains as previously described 18 . E14.5
ICR-strain pregnant mice checked for vaginal plugs were provided by the Animal Center of the Peking University Health Science Center. The pregnant mice were anesthetized by intraperitoneal injection with 0.7% sodium pentobarbital (100 mg/kg). Mouse embryos were exposed in the uterus and 1 µL of DNA solution with 0.01% Fast Green was injected into the lateral ventricles of embryos through a sharped micropipette by a microelectrode beveler BV-10 (Sutter Instrument, USA). Plasmids were prepared in 0.9% sterilizing saline at the concentrations of 1 µg/µL for EYFP, 3 µg/µL for CDYL1b-shRNA, and 6 µg/µL for blank vector, wild-type
. Electrical pulses of 36 V were generated with an Electro Squire portator T830 (BTX, USA) and applied to the cerebral wall for 50 ms each, for a total of five pulses, at intervals of 950 ms. The uterus was then replaced, and the abdomen wall and skin were sutured. After surgical manipulation, pregnant mice were allowed to recover to consciousness in a 37 °C incubator.
Four days after surgery, E18.5 mice were perfused with 0. 
Statistical analysis
Data were analyzed and plotted using GraphPad Prism 6.0 (GraphPad Software, USA).
Statistical methods for comparisons were chosen properly from unpaired t-test and one-way or two-way ANOVA with Tukey's or Bonferroni's multiple-comparisons test as described in figure legends. The statistical credibility was defined as three level: *p<0.05, *p<0.01 and ***p<0.001.
All data are presented as mean ± SEM.
UNC4850 Synthesis and Purification
Fmoc-protected amino acids were purchased from Chem-Impex and Sigma-Aldrich with the exception of the Fmoc lysine derivative which was synthesized as described previously 38 . All other chemicals and solvents were purchased from TCI America and Sigma Aldrich, unless otherwise stated. Syringe reaction vessels were made in-house with 2 mL syringes (Norm-Ject) and frits (Teledyne).
Synthesis was conducted via solid-phase peptide synthesis on Fmoc Rink amide resin (100 mg, Chem-Impex). The resin was initially swollen in DCM followed by DMF (10 minutes each).
Fmoc deprotection was conducted by incubation with a solution of 2.5% 1,8-diazabicycloundec-7-ene and 2.5% pyrrolidine in DMF for 10 min. The resin was filtered and washed twice with DMF, methanol, DMF, and DCM before amino acid for coupling. Standard Fmoc synthesis protocols were used to generate the 6-mer peptide, UNC4850. Briefly, Fmoc-protected amino acids (4 eq) were mixed for 5 minutes with HBTU (4 eq), HOAt (4 eq), and DIPEA (8 eq) in 1 mL of DMF and 1 mL of dichloromethane (DCM). The solution was then added to the resin and left on a shaker at room temperature for 1 hour. The resin was filtered and washed twice with DCM, DMF, methanol, and DMF again. Fmoc amino acid protecting groups were removed as described above, and then the resin was filtered and washed twice with DMF, methanol, DMF, and DCM before adding the next amino acid for coupling. Following installation of the isovaleric acid capping residue, the resin was rinsed 6 times with DCM. Cleavage cocktail (95% trifluoroacetic acid, 2.5% triisopropylsilane, and 2.5% water) was added to the resin, the mixture was left on the shaker for 2 hours, and the filtrate was collected. The resin was rinsed twice with DCM and the filtrates were pooled and concentrated under vacuum. a-c, Crystal structure of the CDY1-H3K9me3 complex. The peptide is colored in magenta and the protein is colored in green. d-e, Crystal structure of the CDYL2-H3tK27me3 complex. The peptide is colored in yellow and the protein is colored in gray. f, Crystal structure of the CDYL2-H3K27me3 complex, the C-terminal helix of CDYL2 is not shown due to its disorder caused by the artificial crystal packing. The interaction residues are shown in stick or sphere mode and the hydrogen bonds are shown as dashed lines. 
